title: Commentary on chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease. Merja H. Voutilainen et al.
authors.affiliation: National Institute on Drug Abuse, Intramural Research Program, USA. bhoffer@intra.nida.nih.gov
authors.forename: Barry J
authors.initials: BJ
authors.lastname: Hoffer
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D009414:Nerve Growth Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D016627:Oxidopamine / Q000633:toxicity; D020734:Parkinsonian Disorders / Q000139:chemically induced / Q000188:drug therapy*; D051381:Rats
chemical_list: C522217:CDNF protein, human; D009414:Nerve Growth Factors; D016627:Oxidopamine